查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840599

植入式心臟整流去颤器市场（按产品类型、适应症、技术和最终用户）—2025-2032 年全球预测

Implantable Cardioverter Defibrillators Market by Product Type, Indication, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

植入式心臟整流去颤器市场预计到 2032 年将成长至 76.6 亿美元，复合年增长率为 6.19%。

主要市场统计数据
基准年2024年 47.3亿美元
预计2025年 50.3亿美元
预测年份：2032年 76.6亿美元
复合年增长率（%） 6.19%

简要概述设备创新、不断发展的临床实践以及卫生系统压力如何再形成ICD 治疗的作用和提供方式。

植入式心臟整流去颤器(ICD) 是现代心臟护理的基石，为面临心臟猝死风险的患者提供挽救生命的治疗。过去十年，随着材料科学、电池技术、感测演算法和远端连接的进步，设备设计、植入技术和辅助监测技术取得了显着发展。这些创新重塑了患者选择、追踪模式和临床结果，同时也在电生理学、设备工程和数位健康领域创造了新的介面。

随着临床实践日益复杂，医院、诊所和门诊手术中心的相关人员必须将不断发展的证据与实际操作相结合。第一级预防指征和二级预防指征之间的相互作用变得更加微妙，如今复杂的风险分层可以告知哪些人将从植入中受益最多。同时，MRI 相容性和远端监控等技术变革扩展了设备的效用，同时也引入了有关设备寿命、互通性和资料管治的新考量。因此，决策者必须在应对监管和报销动态的同时，平衡临床有效性、病人安全性和经济永续性。

技术进步、临床通讯协定的演变以及医疗保健服务的转变从根本上重新定义了 ICD 护理和医疗保健提供者的优先事项。

在技​​术、临床和系统层面力量融合的推动下，ICD治疗正在经历变革时期。微型化和皮下植入式设计降低了操作复杂性和设备相关感染，而导线技术和感测演算法的进步则提高了心律不整的识别率，并减少了不恰当的治疗。除了硬体创新之外，软体增强和基于云端的远端监控也支援纵向资料收集，促进主动设备管理，并透过与远端医疗的整合来增强患者参与度。

法律规范和临床路径正在适应这些进步，这不仅加速了具有增强远端控制功能的MRI相容系统和设备的普及，也提高了真实世界证据和长期安全数据的标准。门诊手术中心的选择性ICD植入手术数量正在增加，而医院和专科心臟中心处理的病例也越来越复杂。总的来说，这些转变正在改变采购优先事项、临床工作流程和价值评估，需要製定整合策略，使产品设计与现代心臟护理的营运现实一致。

检验近期关税政策和贸易动态如何重塑整个 ICD 价值链的供应策略、成本压力和临床准入考虑

关税和贸易政策变化对ICD生态系统的累积影响，正在为製造商、经销商和医疗保健系统带来新的复杂性。关税波动会影响上游零件的成本，包括半导体晶片、电池材料和电子次组件，进而影响筹资策略和供应商多元化。为此，製造商正在审查其采购足迹并重新评估供应合同，以减轻贸易驱动的成本波动的影响。

下游医院和门诊手术中心面临着在保持预算灵活性的同时，持续获取最新设备技术的压力。成本控制与临床需求之间的矛盾促使他们对总体拥有成本、备件库存和前置作业时间进行严格审查。在某些情况下，製造商正在加快区域製造和本地组装计划，以减轻关税的影响并提高准时交付能力。伴随此策略转变的是商业团队和临床相关人员之间更紧密的合作，以根据临床紧急程度和预期结果确定医疗设备的优先分配。最终，贸易政策的变化并非千篇一律，其累积影响受到设备製造商和医疗系统实施的合约结构、监管要求和供应链策略的灵活性的影响。

深度细分洞察，将产品架构、临床适应症、实行技术和医疗保健环境与采用驱动因素和策略机会联繫起来

細項分析揭示了不同产品类型、治疗适应症、赋能技术和护理环境的差异化效用驱动因素和临床实用性。产品类型包括皮下、经静脉和穿戴式ICD，每种类型都满足不同的临床需求。皮下系统优先考虑避免感染和减少血管内硬件，经静脉设备提供起搏治疗和更深入的节律管理功能，可穿戴解决方案则可在高风险时期提供临时保护或支持。基于适应症的患者路径由一级和二级预防范式构建，植入适应症和时机由强调风险分层、合併症概况和预期寿命考虑的决策演算法确定。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将无线远端监控和数据分析整合到 ICD植入中，实现主动患者管理
  • 开发无线皮下 ICD 系统，降低感染风险并提高病患舒适度
  • 在植入装置中实施人工智慧驱动的心律不整检测演算法，以提高治疗准确性
  • MRI 相容去心房颤动可为植入患者提供更广泛的影像
  • 在 ICD 中使用小型电池技术来延长设备寿命并减少更换手术
  • 设备製造商和数位健康平台合作实现无缝患者依从性跟踪

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章植入式心臟整流去颤器市场（依产品类型）

  • 皮下植入式心臟復律去颤器
  • 经静脉ICD
  • 穿戴式ICD

第九章植入式心臟整流去颤器市场（按适应症）

  • 第一级预防
  • 二级预防

第 10 章：植入式心臟整流去颤器市场（依技术）

  • MRI相容
  • 启用远端监控

第 11 章植入式心臟整流去颤器市场（依最终用户）

  • 门诊手术中心
  • 心臟护理中心
  • 诊所
  • 医院

第 12 章植入式心臟整流去颤器市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章植入式心臟整流去颤器市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章植入式心臟整流去颤器市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • BIOTRONIK SE & Co. KG
    • MicroPort Scientific Corporation
    • LivaNova PLC
    • Lepu Medical Technology Co., Ltd.
    • Stryker Corporation
    • ZOLL Medical Corporation
    • Kestra Medical Technologies Inc.
Product Code: MRR-037F3DB25943

The Implantable Cardioverter Defibrillators Market is projected to grow by USD 7.66 billion at a CAGR of 6.19% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.73 billion
Estimated Year [2025] USD 5.03 billion
Forecast Year [2032] USD 7.66 billion
CAGR (%) 6.19%

A concise framing of how device innovation, evolving clinical practice, and health system pressures are reshaping the role and delivery of ICD therapy

Implantable cardioverter defibrillators (ICDs) are a cornerstone of modern cardiac care, providing life-saving therapy to patients at risk of sudden cardiac death. Over the past decade, device design, implantation techniques, and adjunctive monitoring have evolved significantly, driven by advances in materials science, battery technology, sensing algorithms, and remote connectivity. These innovations have reshaped patient selection, follow-up paradigms, and clinical outcomes, while creating new intersections between electrophysiology, device engineering, and digital health.

As the clinical landscape becomes more complex, stakeholders across hospitals, clinics, and ambulatory surgical centers must reconcile evolving evidence with operational realities. The interplay between primary and secondary prevention indications has become more nuanced, with refined risk stratification informing who benefits most from implantation. Concurrently, technology shifts such as MRI compatibility and remote monitoring have expanded device utility, but also introduced new considerations for device longevity, interoperability, and data governance. The resulting environment requires decision-makers to balance clinical efficacy, patient safety, and economic sustainability while navigating regulatory and reimbursement dynamics.

How converging technological breakthroughs, evolving clinical protocols, and care delivery shifts are fundamentally redefining ICD therapy and provider priorities

ICD therapy is undergoing a period of transformative change driven by converging technological, clinical, and system-level forces. Miniaturization and subcutaneous designs are reducing procedural complexity and device-related infections, while advances in lead technology and sensing algorithms improve arrhythmia discrimination and reduce inappropriate therapy. Parallel to hardware innovation, software enhancements and cloud-enabled remote monitoring are enabling longitudinal data capture, facilitating proactive device management, and enhancing patient engagement through telehealth integrations.

Regulatory frameworks and clinical pathways are adapting to these advances, accelerating pathways for MRI-compatible systems and devices with enhanced remote capabilities, but also raising the bar for real-world evidence and long-term safety data. Health systems are responding by evolving care models; ambulatory surgical centers are increasingly performing elective ICD implants, while hospitals and specialized cardiac centers retain complex cases. Collectively, these shifts are changing procurement priorities, clinical workflows, and value assessments, demanding integrated strategies that align product design with the operational realities of contemporary cardiac care.

Examining how recent tariff policies and trade dynamics have reshaped supply strategies, cost pressures, and clinical access considerations across the ICD value chain

The cumulative impact of tariff actions and trade policy changes on the ICD ecosystem has introduced new layers of complexity for manufacturers, distributors, and health systems. Tariff fluctuations affect upstream component costs, including semiconductor chips, battery materials, and electronic subassemblies, thereby influencing procurement strategies and supplier diversification. In response, manufacturers are reassessing sourcing footprints and reevaluating supply contracts to mitigate exposure to trade-driven cost variability.

Downstream, hospitals and ambulatory surgical centers face pressure to preserve budgetary flexibility while maintaining access to the latest device technologies. The tension between cost containment and clinical necessity has prompted greater scrutiny of total cost of ownership, spare parts inventories, and lead times. In some cases, manufacturers are accelerating plans for regional manufacturing or localized assembly to reduce tariff impact and strengthen just-in-time delivery capabilities. These strategic shifts are accompanied by closer collaboration between commercial teams and clinical stakeholders to prioritize device allocations based on clinical urgency and outcome expectations. Ultimately, trade policy changes are not uniform in effect; their cumulative impact is mediated by contract structures, regulatory requirements, and the agility of supply chain strategies implemented by device makers and health systems alike.

Deep segmentation insights that connect product architecture, clinical indication, enabling technologies, and care settings to adoption drivers and strategic opportunities

Segmentation analysis reveals differentiated drivers of adoption and clinical utility across product types, therapeutic indications, enabling technologies, and care settings. Based on Product Type, the landscape includes Subcutaneous ICDs, Transvenous ICDs, and Wearable ICDs, each addressing distinct clinical needs: subcutaneous systems prioritize infection avoidance and reduced intravascular hardware, transvenous devices offer pacing therapies and deeper rhythm management capabilities, while wearable solutions serve as interim protection or as adjuncts for high-risk periods. Based on Indication, patient pathways are framed by Primary Prevention and Secondary Prevention paradigms, with decision algorithms emphasizing risk stratification, comorbidity profiles, and life expectancy considerations that inform candidacy and timing for implantation.

Based on Technology, MRI Compatible and Remote Monitoring Enabled devices redefine post-implant care and diagnostic confidence, as MRI compatibility reduces barriers to advanced imaging and remote monitoring supports proactive device management and early detection of complications. Based on End User, Ambulatory Surgical Centers, Cardiac Care Centers, Clinics, and Hospitals embody different procedural volumes, case complexity, and infrastructure capacities, which in turn influence purchasing criteria, service agreements, and clinical support needs. Understanding these intersecting segment dynamics is essential for targeting innovation efforts, designing differentiated commercial propositions, and aligning clinical training and support services with the environments where devices are implanted and managed.

Regional dynamics and differentiated adoption pathways that illuminate how reimbursement, regulatory maturity, and care delivery models shape ICD access and deployment

Regional dynamics underscore heterogeneous adoption patterns, reimbursement environments, and regulatory frameworks that shape ICD strategy by geography. In the Americas, established reimbursement pathways and high procedural volumes coexist with growing emphasis on cost containment and value-based procurement, prompting device providers to demonstrate comparative effectiveness and long-term performance. The Europe, Middle East & Africa region presents a mosaic of regulatory maturity and healthcare funding models, where some markets rapidly adopt advanced features such as MRI compatibility while others prioritize basic access and affordability, thus requiring differentiated market entry and pricing approaches.

In the Asia-Pacific region, rapid investment in cardiac infrastructure and increasing uptake of minimally invasive techniques are expanding indications for device therapy, but market heterogeneity remains pronounced across public and private systems. Across all regions, regional clinical networks, investigator-led registries, and local guidelines influence adoption curves and post-market evidence requirements. Manufacturers and health systems that tailor value propositions to regional nuances-balancing clinical performance, service models, and pricing-can better navigate reimbursement complexities and accelerate responsible access to device therapy.

Key competitive and strategic company trends highlighting where product innovation, partnerships, clinical evidence, and supply resilience create commercial advantage

Competitive dynamics in the ICD space are characterized by sustained investment in incremental innovation, strategic partnerships, and selective consolidation. Established manufacturers continue to invest in next-generation lead designs, battery chemistries, and sensing algorithms to extend device longevity and reduce adverse events, while newer entrants and smaller firms are focusing on niche innovations such as wearable defibrillators and software-centric monitoring platforms that integrate with care management systems. Strategic collaborations between device companies and digital health firms are accelerating features like predictive analytics and remote monitoring dashboards, which can shift value conversations from device alone to bundled care solutions.

At the same time, intellectual property portfolios and clinical evidence generation remain pivotal competitive levers; firms that can demonstrate long-term safety and real-world effectiveness through registries and post-market studies gain negotiating power with payers and procurement teams. Supply chain resilience and manufacturing flexibility also differentiate competitors, particularly in a climate where trade policy and component scarcity can affect availability. For commercial teams, the competitive imperative is to align product roadmaps with service offerings and clinical support that address the full lifecycle of device use from implantation through long-term follow-up.

Practical strategic priorities that align clinical evidence generation, product design, and supply chain agility to accelerate adoption and preserve commercial resilience

Industry leaders should adopt an integrated approach that aligns product development, clinical evidence strategies, and supply chain resilience to secure sustainable advantage. Prioritize investments in technologies that demonstrably reduce procedural complications and improve patient experience, while ensuring that clinical trials and registries are designed to capture endpoints that matter to payers and providers. Concurrently, diversify sourcing strategies and consider regional assembly or contract manufacturing to mitigate exposure to tariff and trade policy volatility while maintaining quality and regulatory compliance.

Commercial strategies should emphasize bundled value propositions that combine devices with remote monitoring services and clinician support, enabling clearer demonstrations of outcome improvements and total cost implications for health systems. Strengthen collaboration with centers of excellence and clinician champions to accelerate uptake and to co-create training programs that lower the barrier to adoption in ambulatory settings. Finally, invest in data interoperability and cybersecurity measures to ensure that remote monitoring and device data can be integrated into electronic health records and care pathways securely, thereby increasing clinician trust and patient acceptance.

A transparent, clinician-informed research methodology combining expert interviews and systematic secondary review to ensure robust, actionable insights

The research underpinning this report combined primary qualitative engagement with clinical and commercial experts and secondary synthesis of peer-reviewed literature, regulatory filings, and clinical trial registries to ensure a balanced and evidence-based perspective. Primary engagements included interviews with electrophysiologists, device clinic managers, procurement professionals, and supply chain leaders to capture real-world practice patterns and decision criteria. Secondary sources were systematically reviewed for technology assessments, safety profiles, and comparative analyses to triangulate insights and validate thematic findings.

Analytical rigor was maintained through cross-validation of interview findings against published clinical guidelines and regulatory approvals. Limitations were acknowledged where high-quality long-term data are still emerging, particularly for newer subcutaneous and wearable solutions. The methodology emphasized transparency in source attribution and applied qualitative synthesis to translate heterogeneous data into actionable implications for stakeholders. Quality assurance processes included internal peer review and methodological checks to reduce bias and ensure the relevance of conclusions for commercial and clinical decision-making.

A concise synthesis capturing the strategic balance of innovation, evidence, and operational readiness required to advance ICD therapy responsibly and effectively

The implantable cardioverter defibrillator landscape is at an inflection point characterized by meaningful technological progress, shifting care delivery models, and heightened attention to supply chain and policy risks. Advances in device design and remote capabilities offer clear opportunities to improve patient outcomes and streamline follow-up, yet realizing these benefits requires aligned evidence generation, adaptable commercial strategies, and resilient operations. Health systems and manufacturers that proactively bridge clinical needs with pragmatic service models will be best positioned to deliver value while managing cost and access pressures.

Looking ahead, the successful commercialization of ICD innovations will depend on credible long-term safety data, interoperable digital ecosystems, and partnerships that integrate devices into broader care pathways. By focusing on these priorities, stakeholders can navigate regulatory complexity, address payer expectations, and expand responsible access to life-saving therapy across diverse healthcare environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of wireless remote monitoring and data analytics in ICD implants to enable proactive patient management
  • 5.2. Development of leadless subcutaneous ICD systems reducing infection risk and improving patient comfort
  • 5.3. Implementation of AI-driven arrhythmia detection algorithms in implantable devices to enhance therapy accuracy
  • 5.4. Emergence of MRI-compatible defibrillators enabling broader imaging diagnostics for implanted patients
  • 5.5. Adoption of miniaturized battery technology in ICDs to extend device lifespan and reduce replacement surgeries
  • 5.6. Collaboration between device manufacturers and digital health platforms for seamless patient adherence tracking

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Implantable Cardioverter Defibrillators Market, by Product Type

  • 8.1. Subcutaneous ICDs
  • 8.2. Transvenous ICDs
  • 8.3. Wearable ICDs

9. Implantable Cardioverter Defibrillators Market, by Indication

  • 9.1. Primary Prevention
  • 9.2. Secondary Prevention

10. Implantable Cardioverter Defibrillators Market, by Technology

  • 10.1. MRI Compatible
  • 10.2. Remote Monitoring Enabled

11. Implantable Cardioverter Defibrillators Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Care Centers
  • 11.3. Clinics
  • 11.4. Hospitals

12. Implantable Cardioverter Defibrillators Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Implantable Cardioverter Defibrillators Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Implantable Cardioverter Defibrillators Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Boston Scientific Corporation
    • 15.3.3. Abbott Laboratories
    • 15.3.4. BIOTRONIK SE & Co. KG
    • 15.3.5. MicroPort Scientific Corporation
    • 15.3.6. LivaNova PLC
    • 15.3.7. Lepu Medical Technology Co., Ltd.
    • 15.3.8. Stryker Corporation
    • 15.3.9. ZOLL Medical Corporation
    • 15.3.10. Kestra Medical Technologies Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS ICDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY WEARABLE ICDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRIMARY PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SECONDARY PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY MRI COMPATIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REMOTE MONITORING ENABLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CARDIAC CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 83. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 85. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 96. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 106. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 136. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 146. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 147. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 168. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 169. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. ASEAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 178. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 179. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 180. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 181. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. GCC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPEAN UNION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 198. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 199. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. BRICS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 208. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 209. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. G7 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 218. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 219. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. NATO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 229. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 236. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 237. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 245. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 247. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 252. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 253. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 269. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 271. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 276. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 277. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 285. RUSSIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE,